Access High-Quality Biosimilars while reducing healthcare costs in Switzerland
iQone Healthcare Switzerland: Your trusted partner for delivering biosimilars to Swiss healthcare professionals and patients
At iQone, a Celltrion company our sole mission is to ensure that therapeutic advances like biosimilars and breakthrough medicines reach the patients who need them, when they need them.
iQone for you
At iQone, a Celltrion company, we deliver meaningful services to meet your specific needs,
backed by a decade of trusted experience in Switzerland.
Tailored support for you
We offer fast, informed support through our Swiss-based team, with direct access to decision-makers. Your teams benefit from a dedicated contact, experienced field force, training and patient materials.
Trusted local partner
We ensure reliability with local stock and strategic inventory to meet your needs.
Enjoy the stability of a local partner in Switzerland.
Agility at your service
We provide competitive biosimilar pricing, flexible payment terms, and customized conditions. Our logistics ensure next-day delivery, direct ordering, and seamless cold chain continuity.
Leading Biosimilars Portfolio for Swiss Healthcare
iQone & Celltrion offer one of the most comprehensive biosimilar portfolios in Switzerland, with products in oncology, onco-haematology, rheumatology, gastroenterology, pneumology, allergology and dermatology.
.png?width=2000&height=1356&name=lab%20analysis%20(1).png "lab analysis (1)")
Our patient commitment
We prioritize a patient-centric approach, improve access to treatments and support healthcare professionals in delivering quality care.
- Patient centric approach
- Improving access to treatment
- Education and Information
Driving Swiss Market Access Through Strategic Biosimilar and Specialty Partnerships
iQone (a Celltrion company), collaborates with leading manufacturers, hospitals, and distributors to ensure rapid and seamless market access within Switzerland and possibly other countries through the Celltrion network.
%20(1).png?width=2000&height=1393&name=image%20348%20(1)%20(1).png "image 348 (1) (1)")
Our strategic partnerships facilitate efficient Swissmedic approval processes and enable seamless hospital integration for innovative therapies.
Our success hinges on strong, mutually beneficial collaborations, ensuring that advancements made by researchers and manufacturers reach their intended markets effectively.
Join iQone: Make a Difference in Swiss Biosimilars
.png?width=2000&height=1398&name=team%20working%20together%20(1).png "team working together (1)")
Seeking a rewarding career opportunity? iQone offers experienced professionals a chance to make a real impact in the rapidly evolving field of biosimilars
Hear From Our Valued Biosimilar Partners
Discover why leading biosimilar manufacturers, healthcare professionals, and distributors trust iQone Healthcare for Swiss market access and exceptional service:
"We value our open and constructive collaboration with iQone. Our combined success is a result of their intimate knowledge of the Swiss pharmaceutical ecosystem, their connections and their efficient, expert team."
- Celltrion Healthcare
"We support our partners in delivering excellent services to our customers. The straightforward exchange of information and trust that we share with iQone is the optimal basis for our collaboration. With this spirit we perform at our best every day and continue to explore new solutions."
- Avosano Industrie Service AG
"I’m very satisfied with iQone’s service, and especially with how their team solves any problems that arise. They’re always very easy for me to reach, and they help me quickly and unbureaucratically."
- Gastroenterology Specialist
FAQs
Why is iQone joining the Celltrion group?
This integration is the fruit of a solid partnership that has lasted for more than ten years. By joining the Celltrion Group, a world leader in biosimilars, iQone benefits from increased resources, enabling it to develop its product portfolio and improve access to treatment by supporting healthcare professionals in delivering quality care in Switzerland.
Will the iQone name change?
No, the iQone company name will remain unchanged. We will continue to offer the same service and guarantee the quality you know under the ‘iQone’ brand.
Will this affect the products you offer?
No, our current products and their brand names will remain unchanged. You can continue to benefit from the biosimilar medicines you are already using, with the same quality.
Will anything change in the way we work with you?
No, we will continue to offer the same customised service that you already enjoy under the name ‘iQone for You’. All existing collaborations and contracts will continue unchanged. The purpose of this acquisition is to strengthen our innovation and service capabilities to better meet your needs and those of your patients, but it will in no way disrupt the relationship we have built together.
Will iQone be changing location or staff?
No, iQone will keep its head office in Versoix. The current team, including the management, will remain in place, guaranteeing continuity in the service and relationship you have with us.
How will this integration affect customer service?
Customer service will remain exactly the same. We will continue to offer a high-quality, personalised service, and to listen to your every need.
Will current contracts change?
No changes will be made to existing contracts. All existing commitments will continue unchanged, and we look forward to continuing our partnerships.
What happens if I have questions or concerns about this change?
If you have any questions or concerns, please do not hesitate to contact us. You can contact our support team on +41 22 510 29 30 for any further information. We look forward to working with you!
Does the ordering process remain the same or do I have to contact someone else to order?
All the telephone numbers and email addresses for ordering remain the same. You can place your orders here: iqone@avosano.ch or call us on +41 58 230 33 70